Singh, R., Gautam, A., Chandel, S., Sharma, V., Ghosh, A., Dey, D., . . . Ghosh, D. (2021). Computational screening of FDA approved drugs of fungal origin that may interfere with SARS-CoV-2 spike protein activation, viral RNA replication, and post‐translational modification: A multiple target approach. In Silico Pharmacol.
Citação norma ChicagoSingh, Rajveer, Anupam Gautam, Shivani Chandel, Vipul Sharma, Arijit Ghosh, Dhritiman Dey, Syamal Roy, V. Ravichandiran, and Dipanjan Ghosh. "Computational Screening of FDA Approved Drugs of Fungal Origin That May Interfere With SARS-CoV-2 Spike Protein Activation, Viral RNA Replication, and Post‐translational Modification: A Multiple Target Approach." In Silico Pharmacol 2021.
MLA citiranjeSingh, Rajveer, et al. "Computational Screening of FDA Approved Drugs of Fungal Origin That May Interfere With SARS-CoV-2 Spike Protein Activation, Viral RNA Replication, and Post‐translational Modification: A Multiple Target Approach." In Silico Pharmacol 2021.